The Maharashtra Food and Drug Administration (FDA) have raided Snapdeal‘s Mumbai office on Thursday and asked the e-commerce giant to immediately stop selling prescribed drugs as it is against the Section 18 (c) of Drugs and Cosmetics Act, 1940.
“By the Section 18 (c) of Drugs and Cosmetics Act, 1940, to be read with Rule 65, only a licensed retailer is entitled to offer the sale of drugs and that too only on the basis of a prescription by a doctor. The FDA team raided the Snapdeal premises after the receipt of information that various drugs, including the prescription drugs, were being offered for sale and sold through Snapdeal.com. The specific information was with regard to the sale of Ascoril cough syrup and Vigora tablets.”
What Snapdeal said regarding the raid:
“Snapdeal.com is an online marketplace which connects buyers and sellers to provide the widest assortment of products. The sellers selling online are retailers and distributors, small and medium business and large brands who typically sell offline too. Snapdeal acts as an intermediary between the seller and the buyer of the products listed on the platform,” said a statement released by the company.
It further added, “Upon being notified of any such products, we delist them and take appropriate action against such seller. In this case, we have delisted the products and provided all information to the FDA team.”